ArticlePloS one2026
Topological data analysis for predicting disease outbreaks in humanitarian settings: A machine learning approach.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHumanitarian settings are highly vulnerable to infectious disease outbreaks because displacement, crowding, disruption of health services, insecurity, and inadequate water and sanitation often interact in ways that are difficult to capture with conventional prediction models. There is a need for forecasting approaches that can integrate heterogeneous data sources and better represent complex system structure.
methodsWe developed and evaluated a machine-learning framework incorporating topological data analysis to predict cholera and measles surge events (binary indicators per LGA-week) across 97 Local Government Areas in Nigeria between 2018 and 2023. These 97 LGAs represent a selected high-burden subset (12.5%) of Nigeria's 774 LGAs with sufficient surveillance data. Weekly district-level predictors included climate, conflict, displacement, health-system, and socioeconomic variables. Persistent homology was used to derive topological summaries from multivariate risk profiles, and these were combined with selected raw predictors in gradient-boosting models. Outcomes were defined using surveillance-based outbreak thresholds with a 4-week prediction horizon. Model performance was assessed using temporally ordered hold-out validation, with evaluation of discrimination, calibration, and incremental value over baseline models.
resultsThe topological models achieved ROC-AUC of 0.78 (95% CI: 0.74-0.82) for cholera and 0.81 (95% CI: 0.77-0.85) for measles, representing modest improvements of 0.08-0.12 over models using only conventional predictors. At the optimal decision threshold determined using Youden's index on validation data, sensitivity was 0.72 (range across folds: 0.68-0.76) and specificity was 0.82 (range: 0.79-0.85) for cholera, with false alert rates varying from 2.8-3.6 per LGA per year across temporal folds. Topological features contributed 35% of predictive importance. Calibration slopes were 0.94 (cholera) and 0.97 (measles).
conclusionsTopological feature representations provide a modest but meaningful complementary approach for outbreak prediction in complex humanitarian environments. Their value appears to lie in summarizing higher-order structure across multiple interacting risk domains, rather than replacing established epidemiologic indicators. However, routine deployment requires prospective validation and context-specific threshold tuning. Further external validation, operational threshold analysis, and prospective testing are needed before routine deployment in public-health early warning systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.